Anti-mouse CD8α-InVivo

Catalog No.A2102        Batch: A210225

       Clone No.2.43

Print

Anti-mouse CD8α (Clone:2.43)reacts with mouse CD8α. CD8 is a transmembrane glycoprotein that acts as a co-receptor for the T cell receptor (TCR). It binds to class I MHC molecules displayed by antigen presenting cells (APC).

Technical Data

Formulation PBS buffer, pH 7.0
Clone 2.43
Immunogen Mouse CTL clone L3
Isotype Rat IgG2b, κ
Application In vivo CD8+ T cell depletion,WB
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Sterility 6.60 mg/mL
Purity 99%
Protein concentration 6.60 mg/mL
Endotoxin Level <1 EU/mg

Customer Product Validation

Verified customer review of Anti-mouse CD8α-InVivo

Verified customer review of Anti-mouse CD8α-InVivo

Verified customer review of Anti-mouse CD8α-InVivo

Selleck's Anti-mouse CD8α-InVivo has been cited by 36 publications

Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40229277

BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40107246

Nuclear glycine decarboxylase suppresses STAT1-dependent MHC-I and promotes cancer immune evasion [ EMBO J, 2025, 10.1038/s44318-025-00557-3]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40926122

Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response [ Redox Biol, 2025, 85:103711]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40482348

Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway [ J Immunother Cancer, 2025, 13(2)e010252]

https://www.ncbi.nlm.nih.gov/pubmed/?term=39915005

Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer [ J Immunother Cancer, 2025, 13(7)e011948]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40664447

CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity [ Exp Hematol Oncol, 2025, 14(1):106]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40814015

Disulfiram/copper triggers cGAS-STING innate immunity pathway via ROS-induced DNA damage that potentiates antitumor response to PD-1 checkpoint blockade [ Int J Biol Sci, 2025, 21(4):1730-1748]

https://www.ncbi.nlm.nih.gov/pubmed/?term=39990655

Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target [ Cell Rep, 2025, 44(5):115631]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40279244

Impact of gut microbiome on radiotherapy and immunotherapy efficacy in microsatellite-stable colorectal cancer: role of propionic acid and B. fragilis [ Br J Cancer, 2025, 10.1038/s41416-025-03105-2]

https://www.ncbi.nlm.nih.gov/pubmed/?term=40715695

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.